Dr. Sulaiman Al Habib Medical Services Group dividend and valuation
Valuation
Dr. Sulaiman Al Habib Medical Services Group paid SAR 5.02 per share in dividends over the last 12 months (yield 2.4%). Last ex-dividend date: November 1, 2026. The P/E ratio is 29.8. The average price target of 15 analysts is SAR 265.65.
Data as of November 16, 2026
Dr. Sulaiman Al Habib Medical Services Group compared with similar companies
Dr. Sulaiman Al Habib Medical Services Group's P/E (trailing 12 months): 29.8, +80% against the median of a group of 11 similar companies (16.6).
| Metric | Dr. Sulaiman Al Habib Medical Services Group | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 29.8 | 16.6 | 13.3 – 26.2 | High |
| Forward P/E | 28.3 | 13.7 | 11.7 – 20.2 | High |
| EV/EBITDA | 23.1 | 11.3 | 7.58 – 13.7 | High |
| Price/book | 8.78 | 3.82 | 1.84 – 4.92 | High |
| Price/sales | 4.88 | 1.30 | 0.90 – 3.49 | High |
| Gross margin | 29.4% | 35.5% | 27.9% – 43.3% | Middle |
| Operating margin | 18.6% | 18.4% | 11.5% – 19.7% | Middle |
| Net margin | 16.4% | 8.1% | 7.2% – 11.8% | High |
| ROE | 30.4% | 21.2% | 14.8% – 27.7% | High |
| Debt/equity | 1.06 | 0.79 | 0.65 – 1.22 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Dr. Sulaiman Al Habib Medical Services Group: valuation over time
On the latest fiscal year's earnings (2025), Dr. Sulaiman Al Habib Medical Services Group's P/E today is 30.6, below the median of its last 6 fiscal years (41.7; between 36.1 and 48.6 from 2020 to 2025). Relative to earnings, the stock costs less than it used to. The dividend yield (2.4%) is above the median of the last 6 fiscal years (1.7%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | SAR 257.00 | SAR 6.86 | 37.5 | SAR 4.83 | 1.9% |
| 2024 | SAR 280.40 | SAR 6.62 | 42.4 | SAR 4.77 | 1.7% |
| 2023 | SAR 284.00 | SAR 5.85 | 48.6 | SAR 4.32 | 1.5% |
| 2022 | SAR 220.60 | SAR 4.72 | 46.8 | SAR 3.48 | 1.6% |
| 2021 | SAR 161.40 | SAR 3.93 | 41.0 | SAR 2.80 | 1.7% |
| 2020 | SAR 109.00 | SAR 3.02 | 36.1 | SAR 2.10 | 1.9% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- SAR 74.41B
- Enterprise value
- SAR 82.95B
- PEG
- 1.66
- EV/revenue
- 5.44
Profitability and growth
- ROA
- 7.4%
- ROIC
- 9.6%
- Revenue growth (year over year)
- 18.4%
- Earnings growth (year over year)
- 13.2%
Financial health
- Total cash
- SAR 2.1B
- Total debt
- SAR 9.67B
- Current ratio
- 1.08
- Quick ratio
- 0.72
- Altman Z-Score
- 4.48
- Piotroski F-Score
- 5.00
Dividends
- Annual dividend per share
- SAR 5.02
- Dividend yield
- 2.4%
- Payout ratio
- 70.3%
- Ex-dividend date
- November 1, 2026
Analysts and estimates
- Average price target
- SAR 265.65
- Median price target
- SAR 268.00
- High price target
- SAR 310.00
- Low price target
- SAR 183.00
- Analysts with a price target
- 15
- Consensus
- Buy
- Forward EPS
- SAR 7.51
- EPS estimate, current year
- SAR 7.23
Shares and trading
- Beta
- 0.04
- Average volume
- 161.98K
- Shares outstanding
- 350M
- Float
- 101.99M
- Institutional ownership
- 4.5%
- Insider ownership
- 70.9%
